Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved survival in osteosarcoma patients with atypical low vascularization.
Kunz P, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Ruef P, Bohlmann M, Bosch AL, Ewerbeck V, Kinscherf R, Fritzsching B. Kunz P, et al. Among authors: machado i. Ann Surg Oncol. 2015 Feb;22(2):489-96. doi: 10.1245/s10434-014-4001-2. Epub 2014 Aug 26. Ann Surg Oncol. 2015. PMID: 25155396
CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.
Fritzsching B, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Bosch AL, Bernd L, Csóka M, Mechtersheimer G, Ewerbeck V, Kinscherf R, Kunz P. Fritzsching B, et al. Among authors: machado i. Oncoimmunology. 2015 Apr 2;4(3):e990800. doi: 10.4161/2162402X.2014.990800. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949908 Free PMC article.
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
Berlanga P, Muñoz L, Piqueras M, Sirerol JA, Sánchez-Izquierdo MD, Hervás D, Hernández M, Llavador M, Machado I, Llombart-Bosch A, Cañete A, Castel V, Font de Mora J. Berlanga P, et al. Among authors: machado i. Mol Oncol. 2016 Aug;10(7):1043-53. doi: 10.1016/j.molonc.2016.04.004. Epub 2016 Apr 23. Mol Oncol. 2016. PMID: 27155790 Free PMC article.
MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
Patel UB, Brown G, Machado I, Santos-Cores J, Pericay C, Ballesteros E, Salud A, Isabel-Gil M, Montagut C, Maurel J, Ramón-Ayuso J, Martin N, Estevan R, Fernandez-Martos C. Patel UB, et al. Among authors: machado i. Ann Oncol. 2017 Feb 1;28(2):344-353. doi: 10.1093/annonc/mdw616. Ann Oncol. 2017. PMID: 28426108 Free article. Clinical Trial.
536 results